Oncology PracticeHormone therapy raises diabetes risk in breast cancer survivorsApril 24, 2018Breast CancerPatient & Survivor Care
Oncology PracticeOlympiAD: No statistically significant boost in OS with olaparib in HER2-negative mBCApril 16, 2018Breast Cancer
Oncology PracticeCan cN0 and pCR limit axillary surgery in some breast cancer patients?April 9, 2018Breast Cancer
The Journal of Community and Supportive OncologyAnalgesic management in radiation oncology for painful bone metastasesApril 8, 2018Patient & Survivor CareBreast CancerGenitourinary CancerLung Cancer
Oncology PracticeSarcopenia, body fat linked with mortality in nonmetastatic breast cancerApril 4, 2018Breast CancerPatient & Survivor Care
Oncology Practice21-gene assay predicts survival in male and female breast cancerApril 3, 2018Breast CancerPatient & Survivor Care
Oncology PracticeThink about breast cancer surveillance for transgender patientsMarch 30, 2018Rare DiseasesBreast Cancer
Oncology PracticeOver one-third report financial burden from breast cancer treatmentMarch 27, 2018Breast CancerPatient & Survivor Care
Oncology PracticeHDAC inhibition may boost immune therapy efficacy in breast cancerMarch 27, 2018Immuno-oncologyBreast Cancer
Oncology PracticeLate toxicities with PARP inhibitor plus RT in inflammatory breast cancerMarch 23, 2018Breast CancerPatient & Survivor Care
Oncology PracticeAccelerated breast irradiation advocated by ASTRO guidelineMarch 21, 2018Breast Cancer
Oncology PracticeFulvestrant plus neratinib reversed treatment-acquired HER2 mutations in metastatic ER+ breast cancerMarch 19, 2018Breast Cancer
Oncology PracticeGaps exist in receipt of clinically indicated genetic counseling after breast cancer diagnosisMarch 12, 2018Breast CancerPatient & Survivor Care
Oncology PracticeCECCY: Carvedilol didn’t curb cardiotoxicity in breast cancer patientsMarch 11, 2018Breast Cancer
Oncology PracticeAge at time of breast cancer diagnosis differs by race/ethnicityMarch 7, 2018Breast CancerPractice ManagementBusiness of Medicine
